Ignite Creation Date:
2024-05-06 @ 3:56 PM
Last Modification Date:
2024-10-26 @ 2:00 PM
Study NCT ID:
NCT04809584
Status:
TEMPORARILY_NOT_AVAILABLE
Last Update Posted:
2023-05-19
First Post:
2021-03-15
Brief Title:
18F-DCFPyL PETMRI in Regional NodalDistant Metastases Detection in Intermediate HR Prostate Cancer
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
18F-DCFPyL PETMRI for Detection of Regional Nodal and Distant Metastases in Patients With Intermediate and High-risk Prostate Cancer
Status:
TEMPORARILY_NOT_AVAILABLE
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this research study is to see if patients tumor can be identified by 18F-DCFPyL PETMRI scan The radioactive study agent 18FDCFPyL combined with PETMRI scan may be able to identify smaller tumors than the standard of care contrast-enhanced CT or MRI scan
Detailed Description:
This is an expanded access study with a total of 100 participants with newly diagnosed intermediate or high-risk prostate cancer scheduled to undergo prostatectomy and lymph node dissection
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| PROS0103 | OTHER | None | None |
| IRB-58503 | OTHER | Stanford IRB | None |